A detailed history of Alaska Permanent Fund Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 93,699 shares of GILD stock, worth $9.05 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
93,699
Previous 93,699 -0.0%
Holding current value
$9.05 Million
Previous $6.43 Million 22.17%
% of portfolio
0.12%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$63.15 - $72.88 $1.9 Million - $2.19 Million
-30,093 Reduced 24.31%
93,699 $6.43 Million
Q1 2024

Apr 09, 2024

SELL
$71.58 - $87.29 $3.84 Million - $4.68 Million
-53,586 Reduced 30.21%
123,792 $9.07 Million
Q4 2023

Feb 01, 2024

SELL
$73.27 - $83.09 $1.83 Million - $2.08 Million
-25,031 Reduced 12.37%
177,378 $14.4 Million
Q3 2023

Oct 31, 2023

BUY
$73.94 - $80.67 $250,730 - $273,551
3,391 Added 1.7%
202,409 $15.2 Million
Q2 2023

Jul 31, 2023

BUY
$76.01 - $86.7 $1.65 Million - $1.88 Million
21,697 Added 12.24%
199,018 $15.3 Million
Q4 2022

Feb 08, 2023

SELL
$62.32 - $89.47 $658,784 - $945,787
-10,571 Reduced 5.63%
177,321 $15.2 Million
Q3 2022

Oct 31, 2022

BUY
$59.54 - $68.01 $1.68 Million - $1.92 Million
28,226 Added 17.68%
187,892 $11.6 Million
Q2 2022

Aug 09, 2022

BUY
$57.72 - $65.01 $6.72 Million - $7.57 Million
116,393 Added 268.97%
159,666 $9.87 Million
Q1 2022

Apr 26, 2022

BUY
$57.92 - $72.58 $12,568 - $15,749
217 Added 0.5%
43,273 $2.57 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $321,545 - $364,959
4,956 Added 13.01%
43,056 $2.96 Million
Q2 2021

Aug 10, 2021

BUY
$63.47 - $69.35 $209,451 - $228,854
3,300 Added 9.48%
38,100 $2.62 Million
Q3 2020

Oct 29, 2020

BUY
$62.1 - $78.08 $1.17 Million - $1.48 Million
18,900 Added 118.87%
34,800 $2.2 Million
Q1 2020

May 05, 2020

BUY
$62.63 - $80.22 $995,817 - $1.28 Million
15,900 New
15,900 $1.19 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $121B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.